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The cap-binding protein eIF4E is the first in a chain of translation initiation factors  
that recruits 40S ribosomal subunits to the 5’end of eukaryotic mRNA. During cap-
dependent translation, this protein binds to the 5’terminal m7Gppp cap of the mRNA, 
as well as to the adaptor-protein eIF4G. The latter then interacts with small ribosomal 
subunit-bound proteins, thereby promoting the mRNA recruitment process. Here, we 
show apo-eIF4E to be a protein that contains extensive unstructured regions, which 
are induced to fold upon recognition of the cap-structure. Binding of eIF4G to apo-
eIF4E likewise induces folding of the protein into a state that is similar, but not 
identical, to that of cap-bound eIF4E. At the same time, binding of each of eIF4E’s 
binding partners modulates the kinetics with which it interacts with the other partner. 
We present structural, kinetic and mutagenesis data that allow us to deduce some of 
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Translation initiation on the majority of eukaryotic mRNAs relies on the presence 
of a cap structure at the 5’ end of the message. This structure is bound by the cap-
binding protein eIF4E, which also binds to the adaptor protein eIF4G. eIF4G in turn 
can make contact with the ribosomal pre-initiation complex, thus mediating 
recruitment of the 40S subunit to the mRNA (for reviews on general pathways of 
translation initiation in eukaryotes see refs. 1-3). Formation of the molecular chain 
5’cap–eIF4E–eIF4G-MFC-40S (where MFC is the Multi-Factor Complex  comprising 
eIF1, eIF2, eIF3 and eIF5 4) is essential for ribosome recruitment to occur, and 
alterations in the rates of formation and decay of this complex can potentially be used 
to exert translational control (reviewed in ref. 5).  
The structural analysis of binary cap-analog–eIF4E complexes 6; 7 revealed that 
eIF4E in its cap-bound form is a roughly spherical protein with a cleft constituting the 
cap-binding site, and with an extended N-terminal tail of 35 residues that leaves the 
body of the protein at a site distal from the cap-binding pocket. This N-terminal tail 
shows no obvious secondary structure in solution 7 and cannot be detected in electron 
density maps of crystals of the full-length protein 8.  
Cap-binding to eIF4E involves two tryptophan residues located inside the cap-
binding cleft that hold the double ring of the cap in place via π-π stacking interactions 
6; 7. The stability of the cap–eIF4E interaction is further enhanced by hydrogen bonds 
and van-der-Waals contacts with amino acids contained within the cleft. In contrast, 
binding of eIF4G occurs at a site distal from the cap-binding site, and appears to 
involve two sets of structural features of eIF4E. A highly conserved primary sequence 
motif in eIF4G, Tyr-X-X-X-X-Leu-φ, where φ is Leu, Met or Phe 9; 10, contacts the 
likewise highly conserved, cap-distal part of the folded body of eIF4E 10; 11. In 
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addition, portions of eIF4G surrounding the minimal binding motif form a doughnut-
shaped structure enclosing the extended N-terminal tail of eIF4E and induce the 
formation of secondary structure elements in the latter 12. 
A number of published observations have suggested that structural changes occur 
within eIF4E upon cap-binding. Thus, the binding of cap-analogues to human, wheat 
and yeast eIF4E produces changes in CD spectra 13; 14; 15; 16, increases the protein’s 
solubility in vitro 17, releases the human protein from nuclear bodies in vivo 15, and 
protects it from proteolytic degradation 8. The nature of the structural changes during 
cap-binding has not been well understood, although evaluations of CD difference 
spectra recorded with human cap-bound and apo-eIF4E suggested that a region 
involving approximately 40 amino acids undergoes large-scale structural 
rearrangements 15. Consistent with these findings, analyses of the salt-dependence of 
the eIF4E:cap interaction revealed that cap-binding also substantially alters the 
hydration state of the protein 17. 
Taken together, these data indicate that the formation of the cap-binding complex 
involves a complex interplay of changing conformations in its subunits. In the present 
study, we explore the nature of these conformational changes and the effect they have 
on the individual macromolecular interactions within this complex.  
 
Results 
Cap-binding induced alterations in NMR spectra of 15N labeled eIF4E 
Both X-ray crystallography and NMR-based structural studies have shown that the 
largest part of cap-bound eIF4E (ca. 178 residues at the C-terminal end), folds into 
secondary and tertiary structure elements whereas an N-terminal tail of 35 residues is 
unstructured 6; 7; 8; 17. Upon binding of an eIF4G fragment comprising the eIF4E 
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binding site, the folded part extends ca. ten more residues towards the N-terminus, 
because an additional ten-residue segment of eIF4E folds into secondary structure 
elements 12. However, the overall fold of this protein remains largely unaffected. In 
order to examine whether the apo-structure of eIF4E differs significantly from the 
cap-bound structures, we generated cap-free as well as cap-bound, 15N-labelled eIF4E 
and recorded 15N/1H HSQC spectra for the respective samples (Fig 1).  
The 15N/1H correlated spectra for apo-eIF4E are characterised by poor amide 1H 
chemical shift dispersion, with many fewer identifiable peaks than has previously 
been published for the cap-bound protein 7 (Fig. 1A). An examination of the backbone 
NH cross-peaks at low contour threshold reveals the existence of ca. 100 identifiable 
cross-peaks, 113 fewer than for the cap-bound protein. The loss of these peaks 
suggests intermediate timescale motions in the corresponding regions of eIF4E which 
are broadening the NMR resonances beyond detection. Overall, these data are 
consistent with the majority of eIF4E being disordered in the absence of the cap 
structure.  
As the NMR experiments were carried out at pH 6.5, we wanted to investigate 
whether the disordered state of apo-eIF4E was in part caused by this unphysiological 
pH. CD spectra of cap-free eIF4E were therefore recorded at pH 6.5 and 7.5 (data not 
shown). Under the two conditions, we observed indistinguishable spectra, indicating 
that the structural state of apo-eIF4E observed in our NMR experiments is 
representative of the state that occurs at physiological pH. 
In contrast to the spectrum observed with eIF4E alone, addition of cap-analogue to 
our apo-eIF4E preparation generates spectra that are equivalent to those previously 
reported for the largely folded cap-bound form of this protein (Fig. 1b). It appears, 
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therefore, that cap-binding induces the transition of mostly unfolded eIF4E to a folded 
state.  
A qualitative inspection of the spectra in Fig. 1 indicates that apo-eIF4E contains a 
residual folded core. The narrow chemical shift dispersion observed for the cap-free 
eIF4E spectrum indicates that residual structural elements are likely to be 
predominantly alpha-helical, while the extended loss of peak dispersion in the cap-
free state indicates loss of the majority of beta-sheet structure.  
Examining the exact nature of the residual structure of cap-free eIF4E and 
characterizing its conformation would require assigning the resonances and collecting  
structural constraints for the ca. 100 resonances that can be observed with apo-eIF4E, 
which is beyond the scope of the present study. We conclude from this experiment 
that extensive unfolded-to-folded transitions occur in eIF4E during cap-binding, in 
regions that remain to be exactly defined.  
 
Cap- and eIF4G-binding induce similar unfolded-to-folded transitions in eIF4E 
Previous structural work on an m7GDP–eIF4E–eIF4G393-490 complex indicated that 
eIF4G contacts a highly discontinuous epitope on the dorsal surface of eIF4E 12. 
Nevertheless, eIF4G can bind to eIF4E even in the absence of a cap-structure. This 
implies that either the eIF4G binding region is sufficiently folded in apo-eIF4E to be 
bound by this protein, or that the binding region is unfolded in apo-eIF4E but is 
induced to assume the correct fold upon contact with eIF4G. In order to distinguish 
between these two scenarios, we performed an experiment similar to the one 
described above, in which the 15N/1H HSQC spectra of free and eIF4G-bound, 15N-
labelled apo-eIF4E were compared (Fig. 1c). Surprisingly, we found that addition of 
eIF4G to apo-eIF4E results in a spectrum that closely resembles that of cap-bound but 
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eIF4G-free eIF4E (figure 2). A close inspection of the spectra generated by eIF4E in 
the cap-bound and eIF4G-bound binary complexes reveals a subset of amino acids 
that show significant chemical shifts between the two states (these are labelled in 
figure 2a). This subset is primarily made up of amino acids in close contact with the 
cap-structure (figure 2b), suggesting that binding of eIF4G to apo-eIF4E induces the 
latter to assume a similar overall fold to the cap-bound state, but with local 
differences around the cap-binding site. The area around the cap-binding site then 
adopts its final conformation upon contact with the mRNA cap-structure and 
formation of the ternary cap-eIF4E-eIF4G complex. 
The fact that structural features of eIF4E are similar, but not absolutely identical, in 
the cap- and eIF4G bound states led us to ask whether conformational changes in this 
protein during cap-binding might also be communicated to eIF4G. We therefore 
compared spectra obtained with 15N-labelled eIF4G393-490 in a binary complex with 
unlabelled eIF4E, with those for the same protein in a ternary complex with m7GDP 
and eIF4E. An overlay of the two spectra reveals small shifts in cross-peak positions  
of the magnitude of 0.1-0.2 ppm (Fig 3a), that affect mainly amino acids 445-454 and 
480-490 (numbering corresponding to full-length yeast eIF4G1). Figure 3b shows the 
location of amino acids corresponding to shifted peaks in the context of the m7GDP–
eIF4E–eIF4G393-490 ternary complex. We interpret the observed shift changes as small 
changes in the orientation or flexibility of these portions of the eIF4G fragment 
between the binary and ternary state. In conjunction with the chemical shift changes 
seen in eIF4E between the cap-bound and eIF4G bound states, we conclude that 
accommodation of the cap-structure in the cap-binding cleft of eIF4E induces minor 
changes throughout the entire eIF4E:eIF4G393-490 complex. 
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In summary of the data presented so far, our NMR experiments have shown that apo-
eIF4E generates NMR spectra typical of a largely unfolded protein, and is induced to 
adopt a mostly folded conformation upon binding of the cap-analogue m7GDP. A 
very similar, extensive conformational change is also induced by binding of eIF4G. In 
contrast, binding of the second binding partner to pre-formed binary complexes (i.e. 
either binding of eIF4G to cap–eIF4E or binding of cap to eIF4E–eIF4G) leads to 
chemical shift changes in only small peripheral parts of the cap-binding protein 
(compare with reference 12). In the case of the interaction of m7GDP with  a binary 
eIF4E:eIF4G393-490 complex, chemical shift changes are also visible in the eIF4G 
fragment. Any cap-binding induced conformational changes in the complex therefore 
correspond to minor adjustments in the structure or flexibility of both eIF4E and 
eIF4G, rather than the large-scale rearrangements observed with eIF4E alone. 
Different molecular pathways for the association of eIF4E with eIF4G 
Previous work on the association of eIF4G with cap-bound eIF4E indicated that the 
eIF4G393-490 fragment exists in an unstructured state, but folds upon binding to eIF4E 
18. Further work indicated that during the interaction a small part of the unstructured 
eIF4E N-terminal tail also adopts a helical fold 12. Binding of eIF4G to cap-bound 
eIF4E thus involves large folding transitions in eIF4G, and smaller ones in the N-
terminal tail of eIF4E. In contrast, our NMR data indicate that binding of eIF4G to 
apo-eIF4E involves large folding transitions in eIF4E, in addition to those occurring 
in eIF4G.  
In order to investigate whether these differences in association between apo- and cap-
bound eIF4E with eIF4G become apparent in the kinetics of the respective 
interactions, we designed an experiment to carefully compare the two using surface 
plasmon resonance (SPR). GST-eIF4G393-490 was covalently immobilised on a 
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BIAcore sensorchip surface, and cap-bound or cap-free eIF4E then injected over this 
surface. In order to minimise dilution errors, a single dilution series for the different 
eIF4E concentrations was prepared, each dilution split in half, and one aliquot 
supplemented with m7GpppG in eluent buffer while the other was supplemented with 
an equal volume of eluent buffer only. The regeneration conditions used for 
dissociation of the formed complexes after each injection (20 mM HEPES pH 7.5, 6 
M Guanidinium-HCl) were found not to alter surface performance detectably over a 
series of 10 injection cycles (data not shown). 
A comparison of binding curves recorded in the presence and absence of cap-
analog is shown in figure 4a. It is immediately apparent that cap-bound eIF4E binds 
the immobilised eIF4G fragments more rapidly than the apo-form. This difference is 
particularly evident at intermediate eIF4E concentrations (compare injections at 10 
and 20 nM). Moreover, apo-eIF4E generated sensorgrams (in contrast to those 
generated with cap-bound eIF4E) do not fit to a two-step binding model of the form A 
+ B ↔ [AB]* ↔ [AB], where [AB*] is an intermediate complex that can either decay 
into its components or undergo a conformational rearrangement to form the final and 
more stable complex [AB]. While residuals for such a model for cap-bound eIF4E are 
low (χ2=2.0), residuals for the apo-protein are considerably worse (χ2=127) and show 
non-random distribution around the x-axis (Fig. 4b). An F-test comparing the 
residuals for separate and combined fits of the two datasets confirms our conclusion 
derived from visual inspection of the curves, that the binding mechanisms underlying 
the interactions of apo- and cap bound eIF4E with eIF4G are significantly different 
(p<<0.001). Attempts to fit the binding curves to simple Langmuir-binding models of 
the form A + B ↔ [AB] result in bad fits for both data sets (χ2 of 31.3 and 127 for cap 
 10
bound and apo-eIF4E, respectively), indicating that both forms of eIF4E bind to 
eIF4G with more complicated binding models. 
An explanation for our inability to obtain good two-state fits for the apo-eIF4E 
interaction may come from the NMR experiments presented above. In the absence of 
a cap-structure, both eIF4E and eIF4G393-490 initiate the interaction in a fully or partly 
unfolded state, whereas the final complex is largely folded. In this case, there is thus a 
greater number of folding intermediates required than in the case of cap-bound eIF4E. 
If these transitions occur via more than one relatively stable intermediate state, the 
resulting binding curves would not fit to either Langmuir- or two-state binding 
models. In support of this prediction, we find that binding of the Δ35 eIF4E mutant, 
which can only undergo the first step of the interaction, is much less sensitive to the 
presence of cap-analogues than binding of the wild type protein. For the interaction of 
this mutant with eIF4G393-490, small differences can be observed in the presence or 
absence of cap-analogue (Fig. 4c). Estimates of the kinetic constants for the respective 
interactions show a slightly slower on-rate in the presence of cap-analogue, resulting 
in a kD that is reduced by ca 10% compared to the cap-free protein. Importantly, 
however, both interactions show good fits with a simple Langmuir binding model 
(Fig. 4d). This indicates that for both cap-bound and cap-free eIF4E, a very similar 
initial interaction occurs, followed by further steps that appear as a two-step 
interaction in the case of cap-bound eIF4E, but as a different (possibly more complex) 
interaction in the case of apo-eIF4E.  
Visual inspection of the binding curves observed with wild type eIF4E also 
suggests that cap binding alters predominantly later steps of the interaction. This is 
indicated by the fact that the curves show more dramatic changes at lower 
concentrations, where formation of the final complexes makes proportionally larger 
 11
contributions to the sensorgrams; and by direct comparison of the initial slopes of the 
curves immediately following the start of the injection at the highest eIF4E 
concentration.  
 
Molecular mechanism of eIF4E–eIF4G interface formation  
All the data presented up to this point are consistent with our previously developed 
idea that the association of eIF4G with cap-bound eIF4E occurs via a two-stage 
reaction 12, involving at a first stage contacts between eIF4G and the originally 
identified cap-distal binding site on the folded body of eIF4E 10; 11. In a second stage, 
parts of eIF4G adopt a mostly alpha-helical conformation and wrap around the N-
terminal tail of eIF4E, thus providing a much enlarged eIF4E–eIF4G binding 
interface.  
We were interested in defining in more detail the involvement of the individual 
parts of eIF4G393-490 in the two interaction stages. Based on the three-dimensional 
structure of  the ternary complex 12, we selected a number of amino acids that were 
located at the predicted interface between the two proteins and introduced mutations 
at these points (Fig. 5a). As controls, we included a previously characterised mutant 
(Y452A) that does not interact with eIF4E 19, and a deletion of the N-terminal 35 
amino acids of eIF4E which can undergo the initial part of the interaction but can not 
undergo the second step, i.e. formation of the extended binding interface 12. 
Figure 5b shows SPR sensorgrams for injections of 5 and 125 nM eIF4E, 
respectively, on anti-GST-captured GST-eIF4G393-490 for the different combinations 
of mutant and wild type proteins. An eIF4E concentration of 5 nM is far below the 
equilibrium binding constant of 250 nM for the initial interaction, but is above the 
reported equilibrium constant of 2-4 nM for fully formed complexes 12. At the lower 
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concentration, a measurable response is only produced if a conversion into the stable, 
folded complex takes place, whereas for injections at 125 nM the initial interaction 
step makes a significant contribution to the sensorgrams. Comparison of responses at 
the two concentrations therefore enables us to judge whether an individual mutation 
affects the initial interaction or the subsequent folding process.  
eIF4G W472A is the only mutant that, like Y452A, shows no binding at either 
concentration, indicating that mutation of W472 impairs the initial contact between 
the two proteins. All other eIF4G mutants, as well as the eIF4E mutants, show 
binding profiles with intermediate characteristics between the Δ35eIF4E–wteIF4G 
and wteIF4E–wteIF4G interactions. A more detailed analysis of the sensorgrams 
indicates that for these mutants the initial interaction can occur with near-wild-type 
efficiency. Since all of them produce more stable interactions than the Δ35eIF4E–
eIF4G complex, we can further conclude that some conversion of the initial complex 
into a stable complex can take place, but that either the rates of formation or the 
stability of the final complex are reduced. We also tested a version of eIF4E 
combining the two individual mutations (K36A and F68A) that were tested for this 
protein, and found that in this case the effects of the two mutations were additive, 
with the combined mutations closely resembling the binding curve for Δ35eIF4E. A 
summary of rate constants for all interactions extracted from the sensorgrams via 
curve fitting is given in Table 1 (note that for extraction of rate constants from 
binding curves, injections at 4 to 6 different concentrations were used). 
In order to confirm the observed effects of the mutations on the second binding 
step in vivo, we generated yeast strains that contained the mutated versions of eIF4E 
as the only source of this protein. We had previously found that the second binding 
step is not essential to the functioning of the yeast translational apparatus, since yeast 
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dependent on Δ35eIF4E as their only source of eIF4E are viable 12. However, the 
inability of this protein to undergo the second step of the eIF4E–eIF4G interaction 
produces a weak slow growth phenotype12. 
Wild type eIF4E as well as the K36A, F68A, K36A/F68A and Δ35 mutants of this 
protein were expressed from a GAL/PGK1 fusion promoter, which can be regulated 
by varying the glucose/galactose ratio in the growth medium 20. This ratio was set to 
yield eIF4E levels close to those of wild type yeast 11. Under these conditions, the 
eIF4E K36A, F68A single mutations and the K36A/F68A double mutation produced 
growth rates in between wild type and Δ35eIF4E (Table 1). Ranking of the mutants 
according to the reduction in growth rate yields the same order as ranking according 
to the calculated reduction in the second interaction step, thus strongly supporting the 
data generated with the BIAcore system. 
Formation of the extensive binding interface during the second step of the 
interaction was previously shown to be a requirement for the arrest of eIF4E on 
capped mRNAs following eIF4G binding, and for producing detectable signals in 
RNA gel mobility shift experiments 12. We therefore tested our eIF4G mutants for 
their ability to generate band-shifts of capped, radiolabelled RNAs (Fig 5c).  
A quantitative analysis of these results shows that there is a strong relationship 
between the free energy of formation of the binding interface (as calculated from Keq 
final= kdiss1/kass1*(kdiss2/kass2)), and the ability of the complexes to produce signals in the 
gel shift assay (Fig 5d). A reduction in the amount of shifted RNA is to be expected if 
either the rates of formation or the thermodynamic stability of the extensive binding 
interface are reduced. This would lead to lower equilibrium ratios of fully formed vs. 
initial complexes with apo-eIF4E, with only the fully formed complexes being able to 




Our combined NMR and SPR results suggest that assembly of the cap-binding 
complex involves large-scale structural rearrangements in both of its protein subunits 
(summarised in Fig. 6). Apo-eIF4E is at least partially unfolded, but cap binding 
causes the protein to adopt its previously published, largely folded conformation. 
Moreover, eIF4G-binding induces folding of apo-eIF4E to a similar, but not identical, 
structure to that assumed upon cap-binding.  
A large-scale folding event also occurs in the eIF4G fragment upon binding to 
eIF4E 12; 18. The analysis of mutations in both eIF4E and eIF4G described here allows 
us to deduce information about the order of events during this structural transition 
(see Fig. 6). All mutations affecting the initial interaction are either located in the 
dorsal part of the folded body of eIF4E or make contacts with this region, namely the 
eIF4E P38, V71 and W75 mutants described in an earlier study 11, and the eIF4G 
Y452 and W472 mutants described here (Fig. 1B). It is interesting to note that helix 4 
of eIF4G393-490, the so-called “consensus helix” containing the minimal eIF4E-binding 
motif including Y453, is alone able to bind to eIF4E 10. The W472 residue is situated 
14 amino acids towards the C-terminus of this helix, but its mutation can nevertheless 
prevent any interaction with eIF4E. As the exchange from tryptophan to alanine does 
not significantly alter the charge of the mutated region, we can exclude electrostatic 
effects as the reason for the impaired interaction. The inability to bind may therefore 
rather be caused by effects of the W to A exchange on the propensity to form 
secondary structure elements in the surrounding region. Independently of the 
molecular mechanism that prevents the W472 mutant from binding to eIF4E, we can 
conclude that the consensus helix behaves differently in the context of the full-length 
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protein compared to the isolated peptide. Identified eIF4G contact points with eIF4E 
that are important for the initial interaction therefore involve helix 4  and the N-
terminus of helix 5 (numbering according to ref. 12).  
Most of the mutants affecting formation or stability of the extended binding 
interface are located in, or make contact with, the N-terminal tail of eIF4E. This is 
consistent with the observation that the N-terminal tail is required to induce the 
folding of the eIF4G fragment into secondary and tertiary structure elements 12. 
Interesting exceptions to this rule are eIF4E F68 and eIF4G V473 (Fig. 1B). The 
V473 mutation is located in the middle of helix 5, and makes contact with the F68 
residue in eIF4E. Although this contacting pair is located adjacent to the W472 
residue involved in the initial step of the interaction, it clearly is of much less 
importance for the initial interaction than the tryptophan. There are also no contacts 
between this pair and other residues that seem likely to be important for the second 
interaction step. However, the V473–F68 pairing, while dispensable for the initial 
interaction to occur, may be required for correct formation or orientation of eIF4G 
helix 5, which in turn is required for induction of the subsequent formation of helix 1. 
In conclusion, the second step of the [cap–eIF4E]–eIF4G interaction involves the 
formation of eIF4G393-490 helices 1–3, the wrapping of this part of eIF4G around the 
eIF4E N-terminal tail, and formation of the short helix within this part of eIF4E. 
The fact that the interactions of free and cap-bound eIF4E with eIF4G differ 
kinetically (Fig. 4) suggests that distinct intermediate states may exist for apo-eIF4E 
compared to the 5’cap–eIF4E complex. This is not surprising given that the 
interaction between the apo-proteins involves large-scale structural rearrangements in 
both eIF4E and eIF4G, while the interaction in the presence of cap-analog only 
involves such changes in the latter. Despite clear differences in the folding pathways, 
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our NMR experiments suggest that the complexes attained at the end of these 
pathways differ only minimally. Characterisation of the details of the different folding 
trajectories and intermediate eIF4E–eIF4G complex(es) that form in the presence and 
absence of the cap-structure represents an interesting challenge for the future. 
Finally, the biological significance of the described structural changes in eIF4E 
and eIF4G upon cap-binding may be to enable ribosomal complexes to distinguish 
between the respective cap-associated and cap-free eIF4G–eIF4E complexes. 
Preferential binding to mRNA-associated eIF4G would be particularly important if 
the level of 43S available for recruitment to mRNAs is relatively low, since in this 
case any “unproductive” contacts with free eIF4G would reduce the rate of 
“productive” contacts with mRNAs. Alternatively, contacts with cap-bound eIF4E–
eIF4G complexes may signal proximity to the mRNA 5’-end and thus be important 
for start-codon selection. Possibly relevant here is a recent report that mammalian 
eIF4F can prevent eIF5-promoted GTP hydrolysis in 43S complexes in the presence 
of cap-analogs, but not in the cap-free form 21. In a wider context, the folding 
transitions described in this paper reaffirm the biological significance of extensive 
unstructured regions in a diverse range of natural proteins22. 
 
Materials and Methods 
Plasmids, Strains and Protein Expression. eIF4E 14, GST-eIF4G393-490 fragment 12 
and mutant versions of eIF4E or the eIF4G393-490 fragment 23 were generated as 
described previously. Wild-type and mutant eIF4E was synthesized under control of 
the GPF promoter 20 in the S. cerevisiae strain Mata cdc33::LEU2 leu2 ura3 trp 24. 
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Surface plasmon resonance experiments. For all BIAcore experiments, GST-tagged 
eIF4G fragment was immobilised on surfaces of CM5 sensor-chips (BIAcore), and 
eIF4E injected to observe the interactions. 
For the sensorgrams in figure 4, GST-eIF4G393-490 was covalently coupled to the 
dextran matrix using the BIAcore amine coupling kit. A control surface was created 
by coupling unfused GST. Coupling conditions for both proteins were 30 µg/ml at a 
coupling pH of 4.5. 
For all other experiments, anti-GST antibodies from the BIAcore GST capture kit 
were covalently coupled to a sensorchip surface according to the manufacturer’s 
instructions. GST-fused eIF4G fragment were then captured on these antibodies by 
injections at 1 µg/ml in eluent buffer. Control surfaces was created by capturing 
unfused GST. 
eIF4E was dialysed over night against 500-1000 volumes of eluent buffer (50 mM 
HEPES pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.005 % surfactant p20). Following 
dialysis, the dialysis buffer itself was sterile-filtered and used as eluent buffer in order 
to minimise bulk refractive index changes. Association of eIF4E with the eIF4G 
fragments was observed using the “Kinject” procedure with association and 
dissociation times of 2 minutes each, and flow rates of 75 µl/min. Regeneration 
conditions were 30 second injections of 6 M Guanidine-HCl, 20 mM HEPES pH 7.5 
to strip eIF4E from the covalently bound eIF4G fragments. In the case of the anti-
GST captured eIF4G, surfaces were regenerated by two consecutive injections of 10 
mM Glycine at pH 2. 
For data analysis, the interaction of eIF4E with GST was subtracted from interactions 
with the GST-eIF4G fusions. Resulting curves were then analysed by performing 
global or local fittings with the BIAevaluation software (v 4.1), using the pre-
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programmed Langmuir and two-state models of the software. For all fittings, the “RI” 
value was set as a constant with value zero. Where possible, RMax values were verified 
independently of the fitting procedure by saturating the chip surfaces through 
injections of high concentrations of eIF4E.  
NMR. eIF4E, eIF4G393-490 and eIF4E–eIF4G393-490 were expressed using M9 media 
with 15NH4Cl as the sole nitrogen source. Generation of apo-eIF4E and apo-eIF4E–
eIF4G393-490 was performed as described 12. Apo-eIF4E–eIF4G393-490 was further 
purified on a HiLoad G75 Gel filtration column (Amersham-Pharmacia) to ensure 1:1 
stoichiometry. HSQC experiments were performed on a Varian Inova 600 MHz 
Spectrometer with (apo-eIF4E) or without (apo-eIF4E–4G393-490) a cold-probe 
accessory in buffer conditions described in ref. 7 but without the CHAPS. 
Concentrations of apo-eIF4E, m7GDP–eIF4E and apo-eIF4E–eIF4G393-490 complex 
were approximately 0.1, 0.5 and 0.250 mM respectively. 
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 Figure Legends 
 
Figure 1. 15N/1H correlated NMR spectra of 15N-labelled S. ceverisiae eIF4E in the 
apo-form (a), in the presence of m7GDP (b) and in the presence of eIF4G393-490 (c). 
 
Figure 2. Differences between cap-bound and eIF4G-bound eIF4E. (a), overlay of 
eIF4E cross-peaks in the eIF4E-cap (red) and eIF4E-eIF4G393-490 (black) binary 
complexes. The cross-spectra correspond to panels b and c in figure 1. Cross-peaks 
showing significant chemical shifts are labelled. (b), location of the corresponding 
amino acids in the three-dimensional structure of cap-bound eIF4E. 
 
Figure 3. Structural transitions in eIF4G following the binding of the cap analog 
m7GDP to eIF4G-bound eIF4E. (a) Comparison of the spectra recorded for 15N-
labelled eIF4G in complex with apo-eIF4E (red) and cap-bound eIF4E (blue). The 
numbered amino acids are those indicated in red in panel b. (b) Three-dimensional 
structure of an m7GDP–eIF4E–eIF4G393-490 ternary complex. The amino acids in the 
eIF4G fragment showing significant shifts upon cap binding are colored in red.   
Figure 4. The interaction of eIF4E with GST-eIF4G393-490 in the absence or presence 
of the cap-analogue m7GpppG. Binding curves are recorded from SPR experiments as 
described in the text. (a) Binding curves for the interactions of full length eIF4E. The 
more rapid association in the presence of the cap-structure becomes most apparent by 
comparing the 20 and 10 nM injections. (b) residuals for fitting of the curves in a to a 
two-state binding model of the form A + B ↔ AB* ↔ AB (see text for explanation). 
(c) Binding curves for the interactions of Δ35 eIF4E. (d) Residuals for fitting of the 
curves in C to a simple binding model  of the form A + B ↔ AB. 
 22
 
Figure 5. Effects of point mutations on the eIF4E - eIF4G393-490 interaction. (a) 
Positions of the mutations engineered at or near the eIF4E-eIF4G interface. The 
numbering of secondary structure elements is according to ref. 12 for the eIF4G1 
fragment, and according to ref. 7 for eIF4E.  (b) SPR sensorgrams generated by 
injecting eIF4E over anti-GST captured GST-eIF4G393-490. eIF4E was injected at 5 
nM (grey traces) and 125 nM (black traces). (c) Gel shifts performed with 
combinations of radiolabeled, capped RNA, eIF4E, and GST-eIF4G393-490 mutants. 
Under the conditions applied for this experiment, eIF4E-RNA complexes appear as 
bands in the upper part of the gel (indicated by the arrow), whereas free RNA runs off 
the gel. (d) Quantitation of the amount of shifted RNA for each eIF4G mutant, plotted 
against the estimated equilibrium constant for formation of the final, stable eIF4E–
eIF4G complex. Error bars for the amount of shifted RNA represent the standard 
deviations determined from three independent experiments. Error bars for kEq values 
are calculated from the standard deviations of the individual rate constants determined 
from SPR experiments.  
 
Figure 6.  A schematic model of structural transitions during cap-complex assembly. 
During the initial cap-binding step (top line), a region of eIF4E undergoes an 
unfolded-to-folded transition to give the familiar, “cupped-hand” shaped fold of 
eIF4E. Association of this binary complex with eIF4G393-490 is initiated by contacts 
between helices 4 and 5 with the dorsal surface of eIF4E, followed by formation of 
the interlocking eIF4E–eIF4G interface through folding of eIF4G393-490 helices 1-3, 
and a short helix in the eIF4E N-terminal tail. Binding of eIF4G to apo-eIF4E results 
in the formation of similar secondary structure elements in both proteins as in the cap-
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bound state, although small differences exist between the cap-bound and unbound 
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